Published in J Hum Hypertens on December 01, 1990
The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med (2009) 4.10
Treatment decisions for complex patients: differences between primary care physicians and midlevel providers. Am J Manag Care (2009) 0.82
Health promotion in general practice. Pessimism is uncalled for. BMJ (1994) 0.75
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75
White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol (1973) 3.77
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet (1998) 3.41
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Analysis of the pressor dose response. Clin Pharmacol Ther (1982) 2.44
Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther (1981) 2.36
Current concepts: beta-blockers in pregnancy. N Engl J Med (1981) 2.34
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol (1982) 2.06
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet (1983) 2.03
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
Topographic detection of photorefractive keratectomy. Ophthalmology (1998) 1.97
Coordinating and standardizing long-term care: evaluation of the west of Scotland shared-care scheme for hypertension. Br J Gen Pract (1994) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Br J Clin Pharmacol (1983) 1.89
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79
Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection. J Chromatogr (1980) 1.79
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Cardiovascular reflexes in Parkinsonism. Clin Sci (1971) 1.62
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J (1971) 1.60
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond) (1983) 1.56
Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci (Lond) (1985) 1.49
Verapamil pharmacokinetics and apparent hepatic and renal blood flow. Br J Clin Pharmacol (1985) 1.46
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension (1999) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Atenolol in essential hypertension during pregnancy. BMJ (1990) 1.39
The effect of intravascular transfusion for rhesus haemolytic disease on umbilical artery Doppler flow velocity waveforms. Br J Obstet Gynaecol (1989) 1.38
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut (1984) 1.36
Technical report: quantitative assessment of diaphragmatic movement--a reproducible method using ultrasound. Clin Radiol (1992) 1.30
Desmethylimipramine and the hypotensive action of clonidine in the rabbit. Br J Pharmacol (1972) 1.30
Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man. J Hypertens (1985) 1.29
The effect of captopril on the reflex control heart rate: possible mechanisms. Br J Clin Pharmacol (1985) 1.29
Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season. Am J Epidemiol (1972) 1.27
Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit. Br J Pharmacol (1973) 1.27
Prazosin disposition in young and elderly subjects. Br J Clin Pharmacol (1981) 1.24
A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man. Br J Clin Pharmacol (1987) 1.22
Evidence for postjunctional vascular alpha 2-adrenoceptors in peripheral vascular regulation in man. Clin Sci (Lond) (1983) 1.22
Prazosin determination by high-pressure liquid chromatography using fluorescence detection. J Chromatogr (1979) 1.22
The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow. Br J Clin Pharmacol (1985) 1.20
Idiopathic parkinsonism treated with bromocriptine. Lancet (1975) 1.20
Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose. Br J Clin Pharmacol (1980) 1.19
Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension. Br J Clin Pharmacol (1982) 1.19
Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab (1993) 1.18
Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet (1997) 1.18
Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. Clin Sci Mol Med (1977) 1.17
Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur J Clin Pharmacol (1977) 1.16
Oral pharmacokinetics of omeprazole. Eur J Clin Pharmacol (1984) 1.16
Preliminary experience with a hospital blood pressure follow up clinic with nurse practitioner assessment and microprocessor based data retrieval. Br Med J (Clin Res Ed) (1984) 1.16
The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol (1988) 1.16
Kinetic-dynamic relations and individual responses to enalapril. Hypertension (1990) 1.16
Policies for managing hypertensive patients: a survey of the opinions of British specialists. J Hum Hypertens (1990) 1.14
Doppler uteroplacental waveforms in pregnancy-induced hypertension: a re-appraisal. Lancet (1988) 1.14
Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet (1983) 1.14
Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat. Br J Clin Pharmacol (1986) 1.13
Atenolol disposition in young and elderly subjects. Br J Clin Pharmacol (1982) 1.13
The role of adrenal medullary catecholamines in potassium homoeostasis. Clin Sci (Lond) (1984) 1.13
[3H]yohimbine and [3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes. Eur J Pharmacol (1988) 1.13
Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors? Br J Clin Pharmacol (1986) 1.12
Interaction between clonidine and desipramine in man. Br Med J (1973) 1.11
Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. J Cardiovasc Pharmacol (1982) 1.10
Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol. Br J Clin Pharmacol (1980) 1.09
Acute thermoregulatory and cardiovascular effects of 6-hydroxydopamine administered centrally in rabbits and cats. Br J Pharmacol (1972) 1.09
Nifedipine does not influence adrenaline induced hypokalaemia in man. Br J Clin Pharmacol (1983) 1.09
First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child (1984) 1.08
Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res (1975) 1.07
The experiences of an acute stroke unit--implications for multicentre acute stroke trials. J Neurol Neurosurg Psychiatry (1993) 1.06
The influence of angiotensin II-induced vasoconstriction on common carotid artery blood flow and velocity-time profiles in normal women. Ultrasound Obstet Gynecol (1991) 1.06
The influence of naloxone on the circulatory effects of captopril. Br J Clin Pharmacol (1984) 1.06
Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes. Eur J Clin Pharmacol (1986) 1.05
Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension (1995) 1.05
Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit. J Pharmacol Exp Ther (1974) 1.05
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase. J Neurol Sci (1972) 1.05
Nifedipine: individual responses and concentration-effect relationships. Hypertension (1988) 1.03
Concentration effect modelling with converting enzyme inhibitors in man. Br J Clin Pharmacol (1983) 1.03
Hypercholesterolaemia in treated hypertensives: a controlled trial of intensive dietary advice. J Hypertens Suppl (1989) 1.03
The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension. Br J Clin Pharmacol (1986) 1.03
Effect of naloxone on the actions of captopril. Clin Pharmacol Ther (1985) 1.02
Sedative and cardiovascular effects of clonidine and nitrazepam. Clin Pharmacol Ther (1980) 1.02
Regional impairment of cerebral oxidative metabolism in Parkinson's disease. J Neurol Neurosurg Psychiatry (1979) 1.02
Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. Br J Clin Pharmacol (1987) 1.02
Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man. Clin Sci (Lond) (1981) 1.01
Decreased vascular responsiveness to noradrenaline following regular ethanol consumption. Br J Clin Pharmacol (1985) 1.00
Vascular and aldosterone responses to angiotensin II in normal humans: effects of nicardipine. J Cardiovasc Pharmacol (1986) 1.00
Enalapril and autonomic reflexes and exercise performance. J Hypertens Suppl (1983) 1.00
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J (1991) 1.00
Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev (2007) 1.00
Measuring therapy adherence in Parkinson's disease: a comparison of methods. J Neurol Neurosurg Psychiatry (2006) 1.00
Letter: Clonidine overdose. Br Med J (1975) 0.99
Simultaneous assay of 3,4-dihydroxyphenylethylene glycol and norepinephrine in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1985) 0.99